1. Stocks
    2. /
  2. Amryt Pharma (LSE: AMYT)
    3. /

LSE:AMYT (Amryt Pharma)

About amyt

Amryt looks to acquire, build, develop and subsequently monetise drug candidates focused on treating orphan diseases.
Financial Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Amryt Pharma (LSE: AMYT)
Latest News

Investing Articles

Cheap UK shares: 1 I am considering right now

| Jabran Khan

Jabran Khan is always on the lookout for cheap UK shares. Here is one FTSE AIM pick he is currently…

Read more »

Investing Articles

3 cheap UK shares I’d buy right now

| Royston Wild

I'm searching for the best low-cost UK shares to buy as we head towards September. Here are three stocks on…

Read more »

Investing Articles

I think this AIM stock’s price could surge…but I am being patient

| James J. McCombie

Amryt Pharma (LSE: AMYT) might just have the revenues to get its exciting pipeline assets to market now.

Read more »

Investing Articles

2 under-the-radar stocks I’d consider in September

| Royston Wild

Royston Wild looks at two little-known London stocks that could make you solid returns.

Read more »